Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New gene target found for common brain tumors in children

11.11.2004


Scientists at Johns Hopkins have linked a stem-cell gene to a portion of one of the most common childhood brain cancers, opening the door to tailored therapies that block the gene’s tumor-promoting ability.



The gene, called Notch2, whose pathway is known to be an important factor in regulating brain stem-cell growth and survival, has been studied in fruit flies for almost a century. The research team at the Johns Hopkins Pathology Department and Kimmel Cancer Center found that a protein made by the Notch2 gene promotes cancer cell growth by 27 percent in a childhood brain tumor, called medulloblastoma. Their studies, reported in the November 1 issue of Cancer Research, also revealed that children with high Notch2 gene activity fared worse in the course of their disease than those with less activity in Notch2.

The researchers report that a drug first developed for Alzheimer’s disease called DFK-167, which blocks activation of all Notch proteins, reduces growth of cancerous cells in culture by 80 percent, although unwanted side effects and dosing problems may make it a poor choice for treating human brain cancer. But the investigators are testing more potent drugs of the same class and developing new ones that block only the Notch2 pathway. No clinical trials with any drug have yet been planned, the researchers emphasize.


Scientists say that gene amplification - a process in which cells make too many copies of a gene -- is one of the most reliable indicators of a gene’s importance to cancer development. The Johns Hopkins team found Notch2 amplified in six of 40 (15 percent) medulloblastomas and other similar brain tumors. "Just like genetic mutations, amplifications are long-lasting DNA mistakes, as opposed to transient changes in the production of proteins and other gene products," says Charles Eberhart, M.D., Ph.D., assistant professor of pathology at Johns Hopkins. "Finding amplification of Notch2 is a smoking gun tying it to the development of these brain tumors," he added.

In their study, the Johns Hopkins scientists compared levels of a protein marker for Notch2 gene activity to the survival of 35 medulloblastoma patients. Of 11 patients with high levels, seven died. Of 24 patients with no detectable protein, only six died.

Standard surgery and radiation for medulloblastoma cures approximately 60 percent of children, but often results in many neurological and learning disabilities. "We’d like to develop a drug that only affects the Notch2 pathway, since blocking other members of the Notch family may actually have the opposite effect and encourage cancer growth," says Xing Fan, M.D., Ph.D., first author of the study and postgraduate fellow at Johns Hopkins.

In 25 of 30 of the medulloblastomas they studied, Eberhart’s team also found lower levels of Notch1 gene products compared to Notch2. Notch1 proteins normally provide a brake on growth of medulloblastoma cells and blocking their activation would cancel out some of the drug’s effects. "The net effect of any drug will depend on how much of each Notch1 and Notch2 is present, and since we found more Notch2, we think the scale can be tipped toward stopping the cancer," speculates Eberhart.

Close to 2,000 children are diagnosed with brain cancer annually in the United States. One in five childhood brain cancers is a medulloblastoma. The cancer originates in the back of the brain in the cerebellum. Medulloblastoma tumors often are characterized as looking like a large mass of stem cells.

Vanessa Wasta | EurekAlert!
Further information:
http://www.jhmi.edu

More articles from Life Sciences:

nachricht Water forms 'spine of hydration' around DNA, group finds
26.05.2017 | Cornell University

nachricht How herpesviruses win the footrace against the immune system
26.05.2017 | Helmholtz-Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>